1. The Minimal Information About T cell Assays (MIATA) project has two main goals that will be
addressed in a two-step approach:
Mid-term goal of MIATA = Phase 1: Establishment of a minimal information reporting
framework for human T cell immune monitoring methods in scientific publications.
Long-term goal of MIATA = Phase 2: Based on its successful implementation and
substantiated feasibility and usefulness for scientific publications, adapt the reporting
framework for annotations of immune monitoring data sets from human studies for a
central database, possibly in the context of a Human Immunity Project. This will have to
include structured database vocabulary.
MIATA – Scope of Guidelines
Dedicated Website: www.miataproject.org

2. MIATA – Level of Implementation (Phase 1)
• MIATA is still in the preparatory phase (not finalized)
• Several Journal editors have been approached and have expressed great interest
• The core team expects that the final MIATA Guidelines will be published in Q4/2011
• For phase 1 supporting software or a CV/ontology are not needed
• Public Consultation Period
• Consensus Workshop
• Webinars
Guidelines
Version 0.0
Guidelines
Version 1.0
Guidelines
Version 2.0
• Public Consultation Period
• Consensus Workshop planed
for June 2011
Level of Acceptance
• Published at website
• Announced in Immunity
(2009, Vol. 31, p527)
Publication of Guidelines only
after broad acceptance has
been achieved
• Available at website
• Workshop Results published in CII
(2010 / PMID: 21080166)

3. MIATA – Status, Contributors, Funding
Status:
Project is still in a „long“ preparatory phase. A finalized and well-vetted version of the guideline for
reporting in scientific publications should be available by end of 2011
Contributors:
• Core Team (n=15)
• Invited experts (n=25)
• Comments from public consultation period (n=80)
Funding:
Te project has been supported by the Cancer Research Institute‘s Cancer Immunotherapy Consortium
(CRI/CIC) and by the association for Cancer Immunotherapy‘s working group Cancer Immunotherapy
Immunoguiding Program (CIMT/CIP)
Final Consensus Workshop scheduled for June 2011 – FOCIS 2011